Atlas Trials

Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines

Clinical trial NCT01502345 · COMPLETED

Trial details

NCT number
NCT01502345
Sponsor
U.S. Army Medical Research and Development Command
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hemorrhagic Fever With Renal Syndrome
Start date
2012-01-01
Primary completion
2013-01-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.